相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease
Jong-Hyun Park et al.
SCIENCE ADVANCES (2019)
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naive glioblastoma
Erlend Skaga et al.
BMC CANCER (2019)
Evidence of a Causal Association Between Cancer and Alzheimer's Disease: a Mendelian Randomization Analysis
Sahba Seddighi et al.
SCIENTIFIC REPORTS (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment
A. B. Nagaraj et al.
ONCOGENE (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Transcriptomic alterations during ageing reflect the shift from cancer to degenerative diseases in the elderly
Peer Aramillo Irizar et al.
NATURE COMMUNICATIONS (2018)
Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex
Maa O. Quartey et al.
FRONTIERS IN NEUROSCIENCE (2018)
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
Prashant K. Srivastava et al.
NATURE COMMUNICATIONS (2018)
Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes
Jeffrey Cummings
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Local anesthetic systemic toxicity: current perspectives
Kariem El-Boghdadly et al.
LOCAL AND REGIONAL ANESTHESIA (2018)
Glioma and Alzheimer's Disease
Steven Lehrer
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2018)
Investigating the genetic relationship between Alzheimer's disease and cancer using GWAS summary statistics
Yen-Chen Anne Feng et al.
HUMAN GENETICS (2017)
Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets
Bin Chen et al.
NATURE COMMUNICATIONS (2017)
A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information
Yunan Luo et al.
NATURE COMMUNICATIONS (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review
Ovais Shafi
BMC NEUROLOGY (2016)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
John P. M. Finberg et al.
FRONTIERS IN PHARMACOLOGY (2016)
Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining
Ming Zhang et al.
PLOS ONE (2016)
Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain
Joanna S. Fowler et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence
Jane A. Driver
BIOGERONTOLOGY (2014)
Causal analysis approaches in Ingenuity Pathway Analysis
Andreas Kraemer et al.
BIOINFORMATICS (2014)
PubChem applications in drug discovery: a bibliometric analysis
Tiejun Cheng et al.
DRUG DISCOVERY TODAY (2014)
Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer
Luiz Fernando Zerbini et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer's disease (Review)
Zhiyou Cai
MOLECULAR MEDICINE REPORTS (2014)
Enhanced Expression of WD Repeat-Containing Protein 35 via CaMKK/AMPK Activation in Bupivacaine-Treated Neuro2a Cells (Publication with Expression of Concern. See vol. 14, 2019)
Lei Huang et al.
PLOS ONE (2014)
Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies
Ferran Catala-Lopez et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2014)
Recent Developments in the Regulation of Monoamine Oxidase Form and Function: Is the Current Model Restricting Our Understanding of the Breadth of Contribution of Monoamine Oxidase to Brain [dys]Function?
Darrell D. Mousseau et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Experimental Confirmation of New Drug-Target Interactions Predicted by Drug Profile Matching
Laszlo Vegner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
History and Therapeutic Use of MAO-A Inhibitors: A Historical Perspective of MAO-A Inhibitors As Antidepressant Drug
Matilde Yanez et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Topiramate Treatment Improves Hypothalamic Insulin and Leptin Signaling and Action and Reduces Obesity in Mice
Andrea M. Caricilli et al.
ENDOCRINOLOGY (2012)
Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer's Disease
Ling Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1
Christian C. Dibble et al.
MOLECULAR CELL (2012)
Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study
Jennifer L. Whitwell et al.
LANCET NEUROLOGY (2012)
The JAK/STAT Pathway Is Involved in Synaptic Plasticity
Celine S. Nicolas et al.
NEURON (2012)
Exploiting drug-disease relationships for computational drug repositioning
Joel T. Dudley et al.
BRIEFINGS IN BIOINFORMATICS (2011)
Modulation of oxidative stress and tau phosphorylation by the mTOR activator phosphatidic acid in SH-SY5Y cells
Mariko Taga et al.
FEBS LETTERS (2011)
Reduced Sodium Channel Nav1.1 Levels in BACE1-null Mice
Doo Yeon Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Systematic Drug Repositioning Based on Clinical Side-Effects
Lun Yang et al.
PLOS ONE (2011)
Bupivacaine Induces Reactive Oxygen Species Production via Activation of the AMP-Activated Protein Kinase-Dependent Pathway
Jun Lu et al.
PHARMACOLOGY (2011)
Cytokine signaling through the JAK/STAT pathway is required for long-term memory in Drosophila
Tijana Copf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders
Massimo Mantegazza et al.
LANCET NEUROLOGY (2010)
Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Jorge J. Palop et al.
NATURE NEUROSCIENCE (2010)
Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
Eva Kickstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Sodium Channel Molecular Conformations and Antiarrhythmic Drug Affinity
Michael F. Sheets et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2010)
AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3β and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver
Nanao Horike et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Methylphenidate for the treatment of apathy in Alzheimer disease: Prediction of Response Using Dextroamphetamine Challenge
Nathan Herrmann et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
P70S6 kinase mediates tau phosphorylation and synthesis
JJ Pei et al.
FEBS LETTERS (2006)
Akt/GSK3β serine/threonine kinases:: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations
J Ryder et al.
CELLULAR SIGNALLING (2004)
Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
O Bar Am et al.
NEUROSCIENCE LETTERS (2004)
Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease
T Thomas
NEUROBIOLOGY OF AGING (2000)
分享论文
